CN107257786B - 制备噁噻嗪样化合物的方法 - Google Patents

制备噁噻嗪样化合物的方法 Download PDF

Info

Publication number
CN107257786B
CN107257786B CN201580072835.0A CN201580072835A CN107257786B CN 107257786 B CN107257786 B CN 107257786B CN 201580072835 A CN201580072835 A CN 201580072835A CN 107257786 B CN107257786 B CN 107257786B
Authority
CN
China
Prior art keywords
compound
taurolidine
compounds
reaction mixture
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201580072835.0A
Other languages
English (en)
Chinese (zh)
Other versions
CN107257786A (zh
Inventor
R·W·普弗曼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parseweir Therapeutics, Inc.
Original Assignee
Geistlich Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geistlich Pharma AG filed Critical Geistlich Pharma AG
Priority to CN201910974314.4A priority Critical patent/CN110776479A/zh
Priority to CN202310038641.5A priority patent/CN119454714A/zh
Publication of CN107257786A publication Critical patent/CN107257786A/zh
Application granted granted Critical
Publication of CN107257786B publication Critical patent/CN107257786B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/02—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
    • C07C303/04—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof by substitution of hydrogen atoms by sulfo or halosulfonyl groups
    • C07C303/12—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof by substitution of hydrogen atoms by sulfo or halosulfonyl groups by reaction with thionylhalides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D291/00—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
    • C07D291/02—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms not condensed with other rings
    • C07D291/06—Six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/02—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
    • C07C303/18—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof by reaction of sulfides with compounds having functional groups with formation of sulfo or halosulfonyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/02—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
    • C07C303/22—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof from sulfonic acids, by reactions not involving the formation of sulfo or halosulfonyl groups; from sulfonic halides by reactions not involving the formation of halosulfonyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/07—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton
    • C07C309/09—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton containing etherified hydroxy groups bound to the carbon skeleton
    • C07C309/10—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton containing etherified hydroxy groups bound to the carbon skeleton with the oxygen atom of at least one of the etherified hydroxy groups further bound to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/07—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton
    • C07C309/12—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton containing esterified hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/24—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/78—Halides of sulfonic acids
    • C07C309/79—Halides of sulfonic acids having halosulfonyl groups bound to acyclic carbon atoms
    • C07C309/82—Halides of sulfonic acids having halosulfonyl groups bound to acyclic carbon atoms of a carbon skeleton substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/23—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/24—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/23—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/27—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/02—1,2-Thiazines; Hydrogenated 1,2-thiazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
    • C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D419/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CN201580072835.0A 2014-12-19 2015-12-17 制备噁噻嗪样化合物的方法 Active CN107257786B (zh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN201910974314.4A CN110776479A (zh) 2014-12-19 2015-12-17 *噻嗪样化合物、其制备方法和用途
CN202310038641.5A CN119454714A (zh) 2014-12-19 2015-12-17 噁噻嗪样化合物、其制备方法和用途

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462094580P 2014-12-19 2014-12-19
US62/094,580 2014-12-19
PCT/IB2015/059741 WO2016098054A1 (en) 2014-12-19 2015-12-17 Processes for preparing oxathiazin-like compounds

Related Child Applications (2)

Application Number Title Priority Date Filing Date
CN201910974314.4A Division CN110776479A (zh) 2014-12-19 2015-12-17 *噻嗪样化合物、其制备方法和用途
CN202310038641.5A Division CN119454714A (zh) 2014-12-19 2015-12-17 噁噻嗪样化合物、其制备方法和用途

Publications (2)

Publication Number Publication Date
CN107257786A CN107257786A (zh) 2017-10-17
CN107257786B true CN107257786B (zh) 2019-12-24

Family

ID=55077556

Family Applications (3)

Application Number Title Priority Date Filing Date
CN201580072835.0A Active CN107257786B (zh) 2014-12-19 2015-12-17 制备噁噻嗪样化合物的方法
CN202310038641.5A Pending CN119454714A (zh) 2014-12-19 2015-12-17 噁噻嗪样化合物、其制备方法和用途
CN201910974314.4A Pending CN110776479A (zh) 2014-12-19 2015-12-17 *噻嗪样化合物、其制备方法和用途

Family Applications After (2)

Application Number Title Priority Date Filing Date
CN202310038641.5A Pending CN119454714A (zh) 2014-12-19 2015-12-17 噁噻嗪样化合物、其制备方法和用途
CN201910974314.4A Pending CN110776479A (zh) 2014-12-19 2015-12-17 *噻嗪样化合物、其制备方法和用途

Country Status (21)

Country Link
US (2) US10392355B2 (cg-RX-API-DMAC7.html)
EP (2) EP3233813B1 (cg-RX-API-DMAC7.html)
JP (4) JP6746605B2 (cg-RX-API-DMAC7.html)
KR (1) KR102594322B1 (cg-RX-API-DMAC7.html)
CN (3) CN107257786B (cg-RX-API-DMAC7.html)
AU (2) AU2015365348B2 (cg-RX-API-DMAC7.html)
CA (1) CA2971570A1 (cg-RX-API-DMAC7.html)
CY (1) CY1125047T1 (cg-RX-API-DMAC7.html)
DK (1) DK3233813T3 (cg-RX-API-DMAC7.html)
ES (2) ES2907592T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20220313T1 (cg-RX-API-DMAC7.html)
HU (1) HUE058257T2 (cg-RX-API-DMAC7.html)
IL (1) IL252912B (cg-RX-API-DMAC7.html)
LT (1) LT3233813T (cg-RX-API-DMAC7.html)
MX (2) MX392353B (cg-RX-API-DMAC7.html)
PL (1) PL3233813T3 (cg-RX-API-DMAC7.html)
PT (1) PT3233813T (cg-RX-API-DMAC7.html)
RS (1) RS62955B1 (cg-RX-API-DMAC7.html)
SI (1) SI3233813T1 (cg-RX-API-DMAC7.html)
SM (1) SMT202200091T1 (cg-RX-API-DMAC7.html)
WO (1) WO2016098054A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11591302B2 (en) * 2014-12-19 2023-02-28 Geistlich Pharm A Ag Processes for preparing oxathiazin-like compounds
SMT202200091T1 (it) * 2014-12-19 2022-03-21 Geistlich Pharma Ag Processi per preparare composti simili a ossatiazina
CN109476615A (zh) 2016-04-07 2019-03-15 盖斯特里希医药公司 制备噁噻嗪类化合物的方法
KR20190120155A (ko) * 2017-02-27 2019-10-23 시드 리서치 인스티튜트 컴퍼니, 리미티드 항진균 조성물
CN109602744A (zh) * 2018-12-13 2019-04-12 中国人民解放军总医院 荜茇酰胺在制备抗菌消炎药物中的应用
US20220313702A1 (en) * 2019-05-22 2022-10-06 Geistlich Pharma Ag Oxathiazin compounds for inhibiting gapdh
US20220323452A1 (en) * 2019-05-22 2022-10-13 Geistlich Pharma Ag Methods and compositions for inhibiting gapdh
CN114096255B (zh) * 2019-05-22 2024-09-10 盖斯特里希医药公司 用于治疗、预防、抑制或减少细胞因子释放的噁噻嗪二氧化物
CN111617086A (zh) * 2020-07-06 2020-09-04 长春迈灵生物工程有限公司 牛磺罗定在制备抗hpv病毒药物中的应用
CN111671758A (zh) * 2020-07-06 2020-09-18 长春迈灵生物工程有限公司 牛磺罗定在制备抗hiv病毒药物中的应用
BR112023000308A2 (pt) * 2020-07-06 2023-03-28 Acad Of Military Medical Sciences Uso de taurolidina contra vírus
WO2022229907A1 (en) * 2021-04-29 2022-11-03 Geistlich Pharma Ag Antimicrobial and anticancer agents
CN118724762A (zh) * 2024-06-24 2024-10-01 湖南增达生物科技有限公司 一种牛磺酸的制备新工艺
WO2026074499A1 (en) * 2024-10-03 2026-04-09 Geistlich Pharma Ag Methods and compositions for inhibiting c-myc

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4829079A (en) * 1985-12-30 1989-05-09 Roussel Uclaf 1-benzenesulphonyl-2-oxo-5-alkoxypyrrolidines and medical methods of use thereof
WO2006033446A1 (en) * 2004-09-21 2006-03-30 Astellas Pharma Inc. Aminoalcohol derivatives
WO2012024083A1 (en) * 2010-08-18 2012-02-23 Chemtura Corporation Oxathiazine and dithiine oxides as inhibitors of sulfhydryl-dependent biomolecules
WO2013190355A1 (en) * 2012-06-18 2013-12-27 Geistlich Pharma Ag Oxathiazine derivatives as antibacterial and anticancer agents

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1160443B (de) 1961-11-30 1964-01-02 Hoechst Ag Verfahren zur Herstellung von Tetrahydro-oxathiazin-dioxyden
GB1124285A (en) * 1964-10-06 1968-08-21 Geistlich Soehne Ag Novel perhydro-1,2,4-thiadiazine dioxides-(1,1), their preparation and compositionscontaining them
DE1234988B (de) 1964-11-28 1967-02-23 Bayer Ag Verfahren zur Herstellung von Copolymerisaten des Trioxans
GB8617482D0 (en) 1986-07-17 1986-08-28 Geistlich Soehne Ag Pharmaceutical composition
IT1296926B1 (it) 1997-12-05 1999-08-03 Zambon Spa Procedimento per la preparazione di composti ad attivita' antimicotica
US20080275032A1 (en) * 2006-12-29 2008-11-06 Yuefen Zhou Pyridazinone compounds
JP2008222659A (ja) * 2007-03-14 2008-09-25 Asahi Kasei Corp スルホンアミド化合物の製造方法
WO2008149965A1 (ja) 2007-06-07 2008-12-11 Astellas Pharma Inc. ピリドン化合物
US8088824B2 (en) * 2007-08-15 2012-01-03 Reata Pharmaceuticals Inc. Forms of CDDO methyl ester
EP2643308B1 (en) * 2010-11-23 2016-08-17 Biophore India Pharmaceuticals Pvt. Ltd. Process for the preparation of taurolidine and its intermediates thereof
SMT202200091T1 (it) * 2014-12-19 2022-03-21 Geistlich Pharma Ag Processi per preparare composti simili a ossatiazina

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4829079A (en) * 1985-12-30 1989-05-09 Roussel Uclaf 1-benzenesulphonyl-2-oxo-5-alkoxypyrrolidines and medical methods of use thereof
WO2006033446A1 (en) * 2004-09-21 2006-03-30 Astellas Pharma Inc. Aminoalcohol derivatives
WO2012024083A1 (en) * 2010-08-18 2012-02-23 Chemtura Corporation Oxathiazine and dithiine oxides as inhibitors of sulfhydryl-dependent biomolecules
WO2013190355A1 (en) * 2012-06-18 2013-12-27 Geistlich Pharma Ag Oxathiazine derivatives as antibacterial and anticancer agents

Also Published As

Publication number Publication date
AU2015365348A1 (en) 2017-07-13
PT3233813T (pt) 2022-03-14
RS62955B1 (sr) 2022-03-31
NZ733723A (en) 2024-03-22
ES3075341T3 (en) 2026-08-03
DK3233813T3 (da) 2022-03-07
US20190389819A1 (en) 2019-12-26
CN110776479A (zh) 2020-02-11
KR20170113546A (ko) 2017-10-12
EP4011871C0 (en) 2026-05-27
EP4011871A2 (en) 2022-06-15
MX2017008112A (es) 2018-02-09
SI3233813T1 (sl) 2022-05-31
US20180370932A1 (en) 2018-12-27
JP6746605B2 (ja) 2020-08-26
JP2022031717A (ja) 2022-02-22
PL3233813T3 (pl) 2022-05-30
KR102594322B1 (ko) 2023-10-26
LT3233813T (lt) 2022-04-11
JP7449913B2 (ja) 2024-03-14
US10392355B2 (en) 2019-08-27
ES2907592T3 (es) 2022-04-25
AU2019261702B2 (en) 2021-03-25
CY1125047T1 (el) 2023-03-24
MX369462B (es) 2019-11-08
WO2016098054A1 (en) 2016-06-23
JP7688098B2 (ja) 2025-06-03
JP2024028794A (ja) 2024-03-05
AU2019261702A1 (en) 2019-11-28
CN119454714A (zh) 2025-02-18
EP4011871B1 (en) 2026-05-27
AU2015365348B2 (en) 2019-11-28
EP3233813B1 (en) 2022-02-02
EP3233813A1 (en) 2017-10-25
CA2971570A1 (en) 2016-06-23
WO2016098054A9 (en) 2016-12-22
JP2018502909A (ja) 2018-02-01
MX2019013194A (es) 2020-01-13
SMT202200091T1 (it) 2022-03-21
JP7030093B2 (ja) 2022-03-04
JP2020040964A (ja) 2020-03-19
BR112017013188A2 (pt) 2018-04-10
MX392353B (es) 2025-03-24
EP4011871A3 (en) 2022-08-24
HRP20220313T1 (hr) 2022-05-13
IL252912A0 (en) 2017-08-31
US10968190B2 (en) 2021-04-06
CN107257786A (zh) 2017-10-17
IL252912B (en) 2020-01-30
HUE058257T2 (hu) 2022-07-28

Similar Documents

Publication Publication Date Title
JP7688098B2 (ja) オキサチアジン様化合物を作製する方法
TWI428322B (zh) ４-〔４-（｛〔４-氯-３-（三氟甲基）苯基〕胺甲醯基｝胺基）-３-氟苯氧基〕-ｎ-甲基吡啶-２-羧醯胺單水合物
US20170196876A1 (en) Oxathiazine derivatives as antibacterial and anticancer agents
US12534443B2 (en) Processes for preparing oxathiazin-like compounds
CN102245021B (zh) 安莎霉素氢醌组合物
HK40076913A (en) Processes for preparing oxathiazin-like compounds
HK1240209B (en) Processes for preparing oxathiazin-like compounds
HK1240209A1 (en) Processes for preparing oxathiazin-like compounds
CN102114045A (zh) 超临界萃取蟾皮的方法、由此得到的产品和应用
CN104606189B (zh) 一种化合物在制备mTOR抑制剂中的应用
BR112017013188B1 (pt) Processos para a preparação de compostos semelhantes à oxatiazina
JP2006518722A (ja) 膵臓癌、軟部組織の肉腫、精巣腫瘍、リンパ腫、胸腺腫、ウィルムス腫瘍、腎臓癌、黒色腫、肺腫瘍、脳内転移、頭頸部の腫瘍、および乳癌の処置のための、１−（２−クロロエチル）−１−ニトロソ−３−（２−ヒドロキシエチル）ウレアの使用方法
CN103121970A (zh) 苯并咪唑及其衍生物，其药物组合物及其在制备抗抑郁药物中的应用
WO2015136556A2 (en) Compounds for eradicating or inhibiting proliferation of cancer stem cells
KR20150048419A (ko) 신규 ４핵 아렌-루테늄 화합물 및 이를 유효성분으로 함유하는 암질환의 치료 또는 예방용 약학조성물

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1240209

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20260525

Address after: Pennsylvania, USA

Patentee after: Parseweir Therapeutics, Inc.

Country or region after: U.S.A.

Address before: Swiss Lake Lake

Patentee before: GEISTLICH PHARMA AG

Country or region before: Switzerland

TR01 Transfer of patent right